Concepedia

Mark Roschewski

MR

68

Publications

7.1K

Citations

32

H-Index

2010

Active since

Affiliations

National Cancer Institute(Current)

Center for Cancer Research

National Institutes of Health

The University of Texas MD Anderson Cancer Center

Memorial Sloan Kettering Cancer Center

Mark Roschewski is an author at National Cancer Institute specializing in medicine, pathology, and hematology.

ORCID

Top concepts

Publications per year

2010–2024

68

Publications

68

CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma

Ranjana H. Advani, Ian W. Flinn, Leslie Popplewell et al. · New England Journal of Medicine · 2018 · 1.1K citations · Full text

Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels

James N. Kochenderfer, Robert Somerville, Tangying Lu et al. · Journal of Clinical Oncology · 2017 · 553 citations · Full text

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma

Michail S. Lionakis, Kieron Dunleavy, Mark Roschewski et al. · Cancer Cell · 2017 · 484 citations · Full text

, , +5

Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma

David M. Kurtz, Florian Scherer, Michael C. Jin et al. · Journal of Clinical Oncology · 2018 · 472 citations · Full text

Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study

Mark Roschewski, Kieron Dunleavy, Stefania Pittaluga et al. · The Lancet Oncology · 2015 · 449 citations · Full text

, , +12

Rows per page

1–5 of 68